In many applications, the outcome of interest is a mark such that its observation is contingent upon occurrence of an event. With incomplete follow-up data, the marginal mark distribution is, however, nonparametrically nowhere identifiable in many practical situations. To address this problem, we suggest a semiparametric model that postulates a normal copula for the association between the mark and survival time, but leaves the marginals unspecified. We show identifiability of the marginal mark distribution under this model, and propose an inference procedure. The estimated marginal distribution function is consistent and asymptotically normal, and it provides a basis for estimating summaries of the mark. Furthermore, we propose graphical model-checking methods and Kolmogorov-Smirnov-type goodness-of-fit tests. Simulation studies demonstrate that the inference procedure performs well in practical settings. The method is applied to the estimation of lifetime medical cost in a lung cancer trial.
Introduction
A mark is a random variable associated with an event such that its observation is contingent upon occurrence of the event. Examples include lifetime medical cost and quality-adjusted survival time (Olschewski & Schumacher, 1990) . Parametric estimation of the marginal mark distribution is not always feasible, particularly in the case of lifetime medical cost. The distribution of medical cost is highly skewed, and typical parametric distribution families may not provide a good fit. On the other hand, nonparametric estimation is plagued by thorny issues with incomplete follow-up data. First, if the mark is a cumulative measure at the event, such as lifetime medical cost, the induced censoring pattern on the mark scale is typically dependent (Glasziou et al., 1990; Lin et al., 1997) . Secondly and even more troublesome, the marginal mark distribution is nowhere identifiable in many practical situations (Huang & Louis, 1998) . To understand this, consider lifetime medical cost with data collected from a study with a duration of, say, three years. Then no information on medical cost can be observed for those participants who accumulate zero cost within three years and survive beyond the study duration, so that the distribution function of the mark is not identifiable at any point away from zero. This explains why most previous investigations addressed time-restricted marks instead, including Glasziou et al. (1990) , Lin et al. (1997) , Zhao & Tsiatis (1997) and Bang & Tsiatis (2000) . For instance, three-year-restricted cost is the accumulated cost at three years or death, whichever happens earlier, but the time limit is artificial and the timerestricted cost may not be a good approximation of lifetime cost. Huang & Louis (1998) did show that the joint distribution of the mark and survival time is identifiable except for the tail area on the time scale, but this may not be satisfactory when the marginal mark distribution is of interest.
These concerns motivate semiparametric estimation as an attempt to strike a balance between model flexibility and identifiability, and we suggest copula-based models that parameterise the association between the mark of interest and survival time but leave the marginals unspecified.
Since any assumption is untestable in the tail area on the time scale, due to limited study duration, this proposal specifically targets the situations that such tail probability is practically small.
Normal copula model and its identifiability
Let T be the survival time and let U be the mark of interest. Suppose that they have a continuous joint distribution. The normal copula model postulates that
for unspecified increasing transformations H T (.) and H U (.), where BN(ρ) is the standard bivariate normal distribution with correlation coefficient ρ. Define marginal distribution functions F T (t) : = pr(T ≤ t) and F U (u) : = pr(U ≤ u). As implied from (2·1),
where Φ(.) is the cumulative distribution function of the standard univariate normal distribution.
This indicates that the marginal distributions of T and U are completely unspecified. Their association is parameterised by ρ.
Denote the censoring time by C. We work with the classical random censorship mechanism,
where ⊥ represents independence. As a result of censoring, the set of underlying random variables {T, U, C} are observed through
where ∧ is the minimisation operator and I(.) is the indicator function. Originally identified in Huang & Louis (1998) , this data structure is common to various data-collection schemes involving a mark of interest.
Denote the maximum support of X by τ .
Theorem 1.
Under the normal copula model (2·1) and random censorship (2·3), ρ, F T (.) on
are identifiable from the distribution of {X, Y, ∆}.
Thus, the marginal distribution of U becomes identifiable over the whole line under the proposed semiparametric model, unless T and U are perfectly correlated. From now on, we restrict our attention to situations with ρ ∈ (−1, 1); the cases of ρ = ±1 are of little practical interest.
Bivariate copula modelling has been previously employed for the inference of association between random variables, where both marginal distributions can be readily estimated in a nonparametric fashion; see Klaassen & Wellner (1997) as well as Shih & Louis (1995) and Genest et al. (1995) .
However, our current application is different.
Proposed inference procedure

3·1 Estimation of ρ
Suppose that the sample consists of {X i , Y i , ∆ i }, i = 1, . . . , n, as n independent replicates of {X, Y, ∆}. Among the three components in the normal copula model (2·1), F U (.) is of interest whereas F T (.) and ρ may be treated as nuisances. Nevertheless, the estimation of F U (.) requires that of F T (.) and ρ. The standard Kaplan-Meier approach applies to F T (.), and we focus now on ρ.
By normal distribution theory, model (2·1) can be equivalently specified as
with H T (.) and H U (.) given in (2·2). This leads to the following linear transformation model with standard normal error ε:
where θ = ρ(1−ρ 2 ) −1/2 ; that is, upon an unspecified increasing transformation, U is linearly related to H T (T ) with a standard normal error. Write Z = H T (X). The random censorship (2·3) then implies that
Following the idea of Cheng et al. (1995) for linear transformation models, we invoke pairwise comparisons of Y i , i = 1, . . . , n, to obtain the following identity that is free of the transformation
where Z ij = Z i − Z j and Φ 2 (.) is the cumulative distribution function of a normal distribution with mean 0 and variance 2, i.e. Φ 2 (z) = Φ(2 −1/2 z). This is a probit model for I(Y i ≥ Y j ), but with the observations being dependent.
Given (2·2), we estimate H T (.) by H T (.) = Φ −1 { F T (.)}. To avoid technical difficulties arising from the unboundedness of Φ −1 (.) at 0 and 1 and from the tail instability of F T (.), we only consider individuals with X i ∈ [a, b] such that 0 < a < b < τ for constants a and b. Identity (3·3) suggests the following estimating function for θ:
where w(.) is a positive weight function. Following Cheng et al. (1995) , one may adopt w(.) = 1 and w(.) = Φ 2 (.)/[Φ 2 (.){1 − Φ 2 (.)}] to mimic ordinary linear regression and the quasilikelihood approach, respectively, for the probit model with independent observations. Write θ as any zerocrossing of Ψ(ϑ). Since ρ = θ(1 + θ 2 ) −1/2 , an estimator of ρ is obtained as ρ = θ(1 + θ 2 ) −1/2 .
Theorem 2. Suppose that normal copula model (2·1) holds with ρ ∈ (−1, 1). Under random censorship (2·3), ρ converges to ρ almost surely, and n 1/2 ( ρ − ρ) is asymptotically normal with mean 0.
Interval estimation of ρ will be investigated along with that of F U (.), which is the focus of interest.
Identity (3·2) implies that,
Thus,
which is naturally estimated by
Thus, we obtain an estimator of H U (.) in the form
Furthermore, (2·2) suggests an estimator of F U (.) in the form
More explicitly, the estimated marginal distribution F U (.) assigns probability mass to, and only to, those Y values in the subsample {i :
For Y (k) , the assigned probability mass is
Theorem 3. Suppose that normal copula model (2·1) holds with ρ ∈ (−1, 1). Under random censorship (2·3), F U (.) is uniformly consistent for F U (.) almost surely. Furthermore, for any con-
] converges weakly to a zero-mean Gaussian process.
Estimator F U (.) provides a basis for estimating summaries of the mark U . Of particular interest are the mean µ : = E(U ) and the median ν : = inf{u : F U (u) ≥ 0.5}. They are naturally estimated
Corollary 1. Suppose that the conditions in Theorem 3 hold. If U is bounded, µ converges almost surely to µ.
Corollary 2. Under the conditions in Theorem 3, ν converges almost surely to ν, and n 1/2 ( ν− ν) is asymptotically normal with mean 0.
To complete the inference procedure, interval estimation for ρ, F U on [c, d] and ν remains to be addressed. One approach is to derive the influence curves of their maps from the distribution of {X, Y, ∆}; see the definition of these maps in the Appendix. However, the derivation is algebraically
complex. An alternative is empirical or nonparametric bootstrap, which can be justified by the Hadamard-differentiability of these maps as established in the Appendix (Gill, 1989; van der Vaart & Wellner, 1996 , § 3.9).
Model checking
From Huang & Louis (1998) Huang & Louis (1998) derived the nonparametric maximum likelihood estimator for the joint
, regardless of whether the normal copula model holds or not. Meanwhile, our proposal provides a natural estimator under the normal copula model, given by
where Ω(., .; ) is the bivariate normal copula function with correlation coefficient . Then, a goodness-of-fit test may be based on the Kolmogorov-Smirnov statistic
Theorem 4. Suppose that random censorship (2·3) holds. Under the normal copula model (2·1)
Thus, the goodness-of-fit test based on ξ [0,τ ]×(−∞,∞) is consistent against any alternative copula that differs from the normal copula family on [0,
Furthermore, for constants b, c and
] when the normal copula model (2·1) holds with
For critical values of the test, the distribution of ξ B needs to be determined under the normal copula model. Apparently, this distribution is governed by F T (.), F U (.), ρ and F C (.), where F C (t) :
= pr(C ≤ t) is the distribution function of C. If these quantities are given, the distribution function of ξ B can be calculated by the Monte Carlo method. Of course, none of them is known. Nevertheless, we suggest employing the semiparametric bootstrap approach, i.e. using their consistent estimators instead; F C (.) can be estimated by the Kaplan-Meier approach. Note that this bootstrap is different from the nonparametric one in § 3.2, where the bootstrap samples are generated without the normal
, this semiparametric bootstrap for ξ B may be justified by the functional delta method, the same argument as used for the nonparametric bootstrap. In the case of ξ [0,τ ]×(−∞,∞) which is invariant to increasing transformations of the mark scale, the computation can be simplified since F U (.) or its estimator would not be needed. However, since
, there may be technical difficulties with the above asymptotic argument for the semiparametric bootstrap. Nevertheless, our simulation results reported in § 5 provide empirical justification.
Numerical studies
5·1 Preamble
Simulations were conducted to evaluate the proposal with small and moderate samples. We studied the estimation procedure both under the normal copula model and under nonnormal cop-ulas, i.e. when the normal copula model is misspecified. In addition, the goodness-of-fit tests were investigated. Finally, we applied this proposal to the estimation of lifetime medical cost with data from a lung cancer clinical trial.
Instead of using
studies. The resulting estimator is asymptotically equivalent, but had slightly better small-sample performance. Additionally, for each dataset, we chose sufficiently small a and sufficiently large b
In our studies, the use of weight functions w(.) = 1 and The marginal survival distribution was set to be exponential with unit rate. The censoring time followed the exponential distribution with rate 0.2 but curtailed at 2. As such, any event with T > 2, corresponding to the top 13.5% in the survival time, was surely censored. The overall censoring rate was about 25%. Three marginal mark distributions were studied, namely uniform on [0, 12 1/2 ], exponential with unit rate and standard lognormal scaled by (e 2 − e) −1/2 . Their respective means are 3 1/2 , 1 and (e − 1) −1/2 . With the same unit variance, these distributions are in ascending order of long tails; a long-tailed distribution would be expected in the case of medical cost.
For comparison, we investigated two naive approaches to the marginal mark estimation. One treats the observed marks as a random sample from the marginal mark distribution, resulting in the complete-case estimator. The other applies the Kaplan-Meier approach to the mark scale, in the case that the mark is a cumulative measure over time. Let U (.) be the accumulation process.
Unlike the proposed and complete-case estimators, this naive Kaplan-Meier estimator typically depends on the accumulation process by using data {U i (X i ), ∆ i }, i = 1, . . . , n. For this purpose, of coverage probability in these simulation studies, although it needs to be much larger in constructing a reliable confidence interval for a specific dataset. As shown, the proposed estimator for ρ is nearly unbiased and the coverage probability of its nonparametric bootstrap percentile confidence interval is fairly accurate. This seems remarkable with sample size as small as 50. Of more interest is the marginal mark distribution. Note that both the proposed and the completecase estimators of F U (.) at a percentile are invariant to the marginal mark distribution. The naive Kaplan-Meier estimator is so only with special accumulation processes including the one specified.
For F U (.) at the 25th, 50th and 75th percentiles, the performance of the proposed estimator is again remarkable. The proposed mean estimator has small bias and good coverage probability of its confidence interval when the marginal mark distribution is uniform. However, its performance deteriorates with a long-tailed marginal distribution such as lognormal especially in the case of a strong positive association between the mark and survival time. This might be expected because the mean is sensitive to a long tail, which is largely censored under a strong positive association.
The proposed median estimator is presented only for the lognormal marginal mark distribution, with similar and satisfactory performance observed under the other two distributions. In contrast, the two naive estimators are generally biased except for the special circumstance of ρ = 0, when the complete-case estimator for the marginal distribution is consistent and efficient. In this case, the efficiency of the proposed estimator appears to be reasonable.
We also evaluated the semiparametric estimator F T U (t, u) for the joint distribution as given in (4·1), along with the nonparametric Huang-Louis estimator F T U (t, u). Table 2 summarises the results with sample size 50 given at pairs of (t, u), where t takes the 20th, 40th, 60th and 80th percentiles of F T (.), and u takes the 25th, 50th and 75th percentiles of F U (.). Note that these results are invariant to the marginal distribution of U . Given τ = 2, where the censoring time is curtailed, F T U (t, u) is nonparametrically identifiable for all these points under consideration. Both the proposed and the Huang-Louis estimator have negligible bias, but the former is more efficient, as expected.
5·3 Behaviour under nonnormal copulas
In the absence of censoring, the normal copula model turns out to play little role in the estimation; as can be verified, F U (.) is asymptotically equivalent to the empirical marginal mark distribution in this case. However, the presence of censoring is the factor of interest here.
Clayton's and Frank's families (Shih & Louis, 1995) were considered. Copulas in these two families generally differ from normal copulas except when T and U are independent. We adopted the same simulation scenarios as described in § 5.2 except for the copula. Like the normal copula, both of these two nonnormal copula families are governed by a single parameter. In addition, the parameter has a one-to-one mapping with the association measure Kendall's tau within each family.
For comparison purposes, corresponding to each nonzero ρ value considered in § 5.2, we chose a nonnormal copula with the same Kendall's tau. However, only positive association was considered for the Clayton's copula, given its limitation in accommodating negative association.
The results are presented in Table 3 , with sample size 100. In the case of Clayton's family, moderate bias is observed with the marginal mark distribution estimator at the tail. The bias becomes more serious for the mean estimator, especially when the underlying distribution has a longer tail. In contrast, the performance of the median estimator is reasonable. On the other hand, the proposed inference procedure appears to be quite robust with Frank's family. These results suggest that model checking might be important in practice.
5·4 Characteristics of the goodness-of-fit tests
We investigated the Kolmogorov-Smirnov-type goodness-of-fit test based on ξ Table 4 based on 1,000 replications. The critical values were calculated using the semiparametric bootstrap with size 99. For the same reason as for the nonparametric bootstrap, this size is adequate here for assessing the significant levels and powers of the tests. Overall, the achieved significance levels are reasonably accurate, when the normal copula model holds. On the other hand, when the underlying copula belongs to Clayton's or Frank's family, the power of the test increases with sample size although it can be limited with small samples.
5·5 Application to a lung cancer study
Our investigation was largely motivated by the analysis of lifetime medical cost in a randomised trial conducted by the Southwest Oncology Group. This trial compared paclitaxel plus carboplatin versus vinorelbine plus cisplatin therapies in earlier untreated patients with advanced non-small cell lung cancer (Kelly et al., 2001 ). Study outcomes included survival time, as the primary endpoint, and utilised resources which consisted of supportive care medications, blood products, medical procedures, protocol and non-protocol related treatments, and medical care inpatient days or outpatient visits. Cost was assigned to each resource using national databases and was adjusted to 1998 U.S. dollars according to the medical care component of the Consumer Price Index. Previous economic analyses focused on the study-duration-restricted medical cost (Ramsey et al., 2002) or the joint distribution of lifetime medical cost and survival time (Huang & Lovato, 2002; Huang, 2002) .
None of these methods was capable of addressing the marginal distribution of lifetime medical cost directly for each therapy. The current proposal is an effort to fill the gap. As an illustration, we present its application to those participants randomised to the paclitaxel plus carboplatin therapy.
The cost data were collected every 3 months for the first 6 months, and every 6 months thereafter, up to 24 months. After exclusion of those with insufficient documentation or no follow-up for cost data collection, 183 out of the 206 participants randomised to paclitaxel plus carboplatin remained in the current analysis. Approximately 30% of these 183 participants were censored, and the survival rate at 24 months was 19% as estimated by the Kaplan-Meier approach.
We applied the proposed procedure to this dataset. The difference between the mean and median indicates heavy skewness of the distribution. These results contrast the estimated mean two-year-restricted medical cost of $48,940 given in Ramsey et al. (2002) .
For model checking, we employed the methods developed in § 4. Figure 2 shows the scatterplot 
Final remarks
Although the focus of this article is on the normal copula model, the marginal identifiability result may be extended to any copula family so long as its members can be discriminated from each Given that statistical analysis should be mainly driven by data, we would recommend this proposal only when F T (τ ) is sufficiently large that the model assumption can be reasonably checked. If
is small, any approaches to the marginal mark estimation would be inevitably model-driven to a high degree.
The proposed inference procedure has a minimal data requirement. In practice, additional information could be available. For example, in the case of lifetime medical cost, one might also observe accumulated cost at censoring time for each censored individual, or the cost accumulation process at discrete time points as in the study discussed in § 5.5. In that case, more efficient estimation might be possible. However, a general approach to taking advantage of such additional information is not likely to be available and developments might need to be tailored to each specific situation.
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where (T 1 , U 1 ) and (T 2 , U 2 ) are independent replicates of (T, U ). The identifiability of ρ then follows. 2
Proof of Theorem 2. We first show that ρ is a plug-in estimator in a map from the distribution of {X, Y, ∆} to ρ; that is, ρ can be obtained by substituting the empirical distribution of {X, Y, ∆} into the aforementioned map. We then use the functional delta method (Gill, 1989; van der Vaart & Wellner, 1996, § 3.9) to establish the properties of ρ.
Write their respective empirical counterparts as F XY ∆ , F X∆ and
Note that
where z 12 = z 1 − z 2 . Obviously, its theoretical counterpart is
Identity (3·3) implies that
• which clearly has a zero-crossing at θ. Since w(.) is positive and Φ 2 (.) is monotone, (θ − ϑ)Ψ(ϑ) is 0 only if ϑ = θ. Therefore, the zero-crossing is unique, and so we can write θ = Ψ −1 (0). It now becomes clear that ρ is a plug-in estimator in the map F XY ∆ → ρ, which is decomposed as
Next, we show that the map F XY ∆ → ρ is Hadamard-differentiable, working with appropriate spaces of univariate and bivariate cadlag functions endowed with supnorm; see Neuhaus (1971) and van der Vaart & Wellner (1996, § 3.9) . The Hadamard-differentiability of the maps F XY ∆ → {F X∆ , F XY,∆ • =1 } and θ → ρ is obvious, and that of the maps
and Ψ → θ directly follows the results in van der Vaart & Wellner (1996, § 3.9) . The remaining decomposed map is F ZY,∆ • =1 → Ψ. From (A·1), this map is further decomposed into the inner and outer integrations. The former is linear and continuous, and hence Hadamard-differentiable, whereas Gill et al. (1995, Lemma 5 .1) asserted the Hadamard-differentiability for the latter. The chain rule now yields the Hadamard-differentiability of F XY ∆ → ρ.
The continuity of F XY ∆ → ρ is implied by the Hadamard-differentiability. Since F XY ∆ is strongly consistent for F XY ∆ by the Glivenko-Cantelli theorem, ρ is strongly consistent for ρ. By the functional delta method, the asymptotic normality of ρ follows that of
] as follows:
It can be verified that F U is the plug-in estimator in the above map. We use the same approach as in the proof of Theorem 2 to establish the strong consistency and asymptotic normality of F U on [c, d] .
We now show the strong consistency of F U with the support extended to the whole line. Note that F U (.) is a proper cumulative distribution function with monotonicity, F U (−∞) = 0 and
Similarly,
Given the strong consistency of 
